Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate whether Endoplasmic Reticulum (ER) stress pathway is activated in peripheral tissues (adipose tissue) in insulin resistant diabetic patients compared to healthy subjects normoglycemic matched for age and sex an to investigate whether ER stress pathway can be activated in response to insulin. Indeed, some preliminar on rates studies shows that ER stress pathway is activated by insulin in liver and adipose tissue showing that hyperinsulinemia might help trigger stress path ER.
For this, we propose a case control study of type 2 diabetic patients vs control subjects in which markers of ER stress will be evaluated from abdominal subcutaneous adipose tissue obtained before and after euglycemic hyperinsulinemic. We chose to consider adipose tissue subcutaneous rather than visceral adipose tissue for obvious reasons of lesser invasiveness.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control | control subjects with :
|
| |
| case | Diabetic patients with :
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No intervention | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Show an increase in markers of ER stress in fasting patients with type 2 diabetes | Protein expression markers of ER stress pathway BiP / GRP 78, CHOP, ATF4 EDEM and XBP-1 | 2 days |
| Measure | Description | Time Frame |
|---|---|---|
| Assess whether insulin induces an increase in markers of ER stress | Insulin sensitivity | 2 days |
| Insulin secretion in response to glucose infusion | 2 days |
Not provided
Inclusion Criteria:
Specific criteria for control subjects:
Common criteria for patients and control subjects:
Exclusion Criteria:
Not provided
Not provided
Patients with type 2 diabetes Healthy volunteers Adults
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Saint-Louis Hospital | Paris | Paris | 75010 | France |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
blood samples. These samples will be anonymized, frozen and stored in the INSERM UMR-S 872 in the Cordeliers Research Center (Madame Fabienne Foufelle) under the responsibility of Professor Jean-François Gautier for a maximum period of 15 years, beyond which they will be destroyed. These samples will be destroyed at any time at the request of the patient. This DNA storage will be used to study genes related to the secretion of insulin and to identify other genes involved in the onset of diabetes.
| Insulin secretion in response to arginine infusion | 2 days |
| Lipolysis on insulin | 2 days |
| D004700 | Endocrine System Diseases |